ROCKVILLE, Md., Sept. 14 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. announced today that its presentation at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference in London will be webcast and may be accessed at www.hgsi.com
(Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )
A member of Human Genome Sciences’ senior management team will present an overview of the company on Tuesday, September 18, 2007 at 2:20 pm London Time, or 9:20 am Eastern Time.
Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.
The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.
HGS and Human Genome Sciences are registered trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the company’s web site at www.hgsi.com.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comHuman Genome Sciences, Inc.
CONTACT: Jerry Parrott, Vice President, Corporate Communications,+1-301-315-2777, or Kate de Santis, Director, Investor Relations,+1-301-251-6003, both of Human Genome Sciences, Inc.
Web site: http://www.hgsi.com/
Company News On-Call: http://www.prnewswire.com/comp/121115.html /
